Lash Lawrence H
Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, USA; email:
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):507-527. doi: 10.1146/annurev-pharmtox-022724-120525. Epub 2024 Dec 17.
The halogenated solvent trichloroethylene (TCE) has had many uses in medicine, construction, consumer products, and the military. Many of these uses have been discontinued or restricted due to its toxicity, which affects multiple target organs and includes both acute, high-dose toxicity and chronic, low-dose toxicity that also encompass several cancers. US and international agencies have conducted risk and hazard assessments for TCE, with comprehensive publications coming out in the last 10-15 years. Accordingly, the focus of this article is to review recently published data since that time (i.e., 2014) that clarify unsettled questions or provide additional insights into the metabolism and mechanisms of toxicity of TCE in several target organs. Besides metabolism, the review focuses on the kidneys, liver, immune system, nervous system, cardiovascular and pulmonary systems, the search for biomarkers, and recent analyses of human cancer risk and incidence from TCE exposure.
卤代溶剂三氯乙烯(TCE)在医学、建筑、消费品及军事领域有诸多用途。因其毒性,许多此类用途已被停止或受限,TCE的毒性会影响多个靶器官,包括急性高剂量毒性和慢性低剂量毒性,后者还包括几种癌症。美国和国际机构已对TCE进行了风险和危害评估,在过去10至15年中有全面的出版物问世。因此,本文的重点是回顾自那时(即2014年)以来最近发表的数据,这些数据澄清了未解决的问题,或为TCE在几个靶器官中的代谢和毒性机制提供了更多见解。除代谢外,综述重点关注肾脏、肝脏、免疫系统、神经系统、心血管和肺部系统、生物标志物的寻找,以及近期对TCE暴露所致人类癌症风险和发病率的分析。